The HEALTH | AUGUST, 2018

( Left to right) Elements Medical Fitness Family Medicine specialist Dr Raja Ahmad Shaharul, Roche( Malaysia) Sdn Bhd general manager Lance Duan, Zurich Switzerland University Hospital Lung and Thoracic Oncology Centre head Professor Dr Rolf Stahel and Beacon International Specialist Centre medical director Dato Dr Mohamed Ibrahim Dato’ A. Wahid launching the Tecentriq.

ROCHE( Malaysia) Sdn Bhd recently launched Tecentriq( atezolizumab), a programmed death-ligand 1( PD-L1) inhibitor for the treatment of patients with Non-Small Cell Lung Cancer( NSCLC).

Tecentriq is indicated for the treatment of patients with metastatic NSCLC who have disease progression during or following platinum-containing chemotherapy.

An approved cancer immunotherapy designed to target the PD-L1 protein, Tecentriq is formulated to work with the body’ s immune system to attack cancer cells. In a healthy immune system, the molecule PD-L1, which is found on T-cells, works as a stop switch that prevents them from attacking normal cells. Some cancer cells

Dove Dermaseries collection.

DOVE recently launched their Dermaseries collection consisting of four products tailored to the needs of dry and sensitive skin, cleansers that will protect the stratum corneum, enabling the skin to rebuild its lipid barrier while reducing moisture loss, nourishing and sealing dry skin and skin lipids.

Pantai Hospital Cheras, Consultant Dermatologist, Dr Irene Lee Chew Kek pointed out to the importance of moisturising oneself as a daily routine depending on the skin condition and environment. that contain a large amount of PD-L1 can avoid being detected and destroyed by the T-cells. Tecentriq functions to block the activity of PD-L1, thereby stimulating the immune response against cancer cells.

Following the largest global, multicentre, randomised, openlabel, controlled study, Phase III OAK, Tecentriq was found to help NSCLC patients who were previously treated with platinum-based chemotherapy to live longer and feel better than conventional chemotherapy( docetaxel). Results showed that the treatment helped patients live a median of 13.8 months, which is 4.2 months longer than those in the docetaxel group. It also provides durable antitumour responses for patients with a median of 16.3 months.

In addition, she said that if it was just dry skin, moisturiser can be applied twice a day especially after bath.

Real women with real conditions

Unilever, Dove Dermaseries, Global Brand director, Tati Lindenberg said the campaign uses real women with real conditions in order to be more relatable to the customers.

“ We developed this campaign to ensure that women celebrate their skin with confidence,” she said.

The automated EWS system helps the care team recognise changes in a patient’ s condition which enables them to respond immediately.

The first hospital in Asia Pacific to implement automated vital signs measurements and early warning scoring( EWS)

AGAN Specialist Centre recently

Bagan Specialist Centre envisions to be the hospital of choice for affordable value-based quality healthcare in mainland Penang and northern Malaysia.

With integrated digital technology, the automated EWS system helps the care team recognise changes in a patient’ s condition so they can respond earlier, ultimately improving

GlaxoSmithKline Consumer Healthcare Sdn Bhd(“ GSK”), the manufacturer of Polident recently held an education forum entitled‘ Eat, Speak and Smile with Confidence’ with an aim to empower denture wearers.

Polident offers denture care products formulated to provide a firmer hold and cleaner dentures, to improve the comfort and oral health of people who wear dentures or partials. The Polident low-abrasive denture cleansers are formulated specifically to keep your dentures clean, fresh and to maintain daily oral hygiene. It kills 99.9 per cent of odour-causing bacteria and its non-abrasive formula cleans dentures without scratching its surface pores thereby preventing bacterial growth. quality of care, patient safety as well as patient experience. Hospitals using this solution around the world have been able to reduce unexpected cardiac arrests, shorten length of hospital stays for their patients, cut down on patient transfers to critical care and free up more time for patient care.

The centre is scheduled to be ready by 2019 and will have more than 300 inpatient beds to cater for the ever-growing medical tourism market in Malaysia.

Meanwhile, Polident’ s range of denture adhesives are formulated to improve denture comfort by holding dentures tight for up to 12 hours and sealing out irritating food particles, giving wearers the confidence and reassurance to live through the day without worries.

As a continuation of‘ Eat, Speak and Smile with Confidence’ initiative, denture wearers are given a chance to try Polident products through its our Polident Money Back Guarantee programme nationwide throughout July and August.